Subchronic/chronic toxicity of a mixture of four chlorinated dibenzo-p- dioxins in rats: II. Biochemical effects

Toxicology and Applied Pharmacology

Volumn 151, Issue 1, 1998, Pages 70-78

  Viluksela, Matti ^a,b   Stahl, Bernhard U ^a,c   Birnbaum, Linda S ^d   Rozman, Karl K ^a,c  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

^d U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIBENZODIOXIN DERIVATIVE; ETHOXYRESORUFIN;

ANEMIA; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUTOPSY; BLEEDING; CHRONIC TOXICITY; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; FEMALE; MALE; NONHUMAN; POLLUTANT; RAT; RISK ASSESSMENT; SEX DIFFERENCE; STRUCTURE ACTIVITY RELATION; TOXICITY TESTING;

ANIMALIA; ERAGROSTIS TEF;

EID: 0031751778     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1998.8412     Document Type: Article

References (29)

1. Ahlborg, U. G., Brouwer, A., Fingerhut, M. A., Jacobson, J. L., Jacobson, S. W., Kennedy, S. W., Kettrup, A. A. F., Koeman, J. H., Poiger, H., Rappe, C., Safe, S. H., Seegal, R. F., Tuomisto, J., and van den Berg, M. (1992). Impact of polychlorinated dibenzo-p-dioxins, dibenzofurans and biphenyls on human and environmental health, with special emphasis on application of the toxic equivalency factor concept. Eur. J. Pharmacol. 228, 179-199.
2. DeVito, M. J., and Birnbaum, L. S. (1995). The importance of pharmacokinetics in determining the relative potency of 2,3,7,8-tetrachlorodibenzo-p-dioxin and 2,3,7,8-tetrachlorodibenzofuran. Fundam. Appl. Toxicol. 24, 145-148.
3. Gibaldi, M., and Perrier, D. (1975). Pharmacokenetics. Marcel Dekker Inc., New York.
4. Gorski, J. R., Muzi, G., Weber, L. W. D., Pereira, D. W., Arceo, R. J., Iatropoulos, M. J., and Rozman, K. (1988a). Some endocrine and morphological aspects of the acute toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Toxicol. Pathol. 16, 313-320.
5. Gorski, J. R., and Rozman, K. (1987). Dose-response and time course of hypothyroxinemia and hypoinsulinemia and characterization of insulin hypersensitivity in 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-treated rats. Toxicology 44, 297-307.
6. Gorski, J. R., Weber, L. W. D., and Rozman, K. (1988b). Tissue-specific alterations of de novo fatty acid synthesis in 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-treated rats. Arch. Toxicol. 62, 146-151.
7. Gorski, J. R., Weber, L. W. D., and Rozman, K. (1990). Reduced gluconeogenesis in 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-treated rats. Arch. Toxicol. 64, 66-71.
8. Kutz, F. W., Barnes, D. G., Bretthauer, E. W., Bottimore, D. P., and Greim, H. (1990). The international toxicity equivalency factor (I-TEF) method for estimating risks associated with exposures to complex mixtures of dioxins and related compounds. Toxicol. Environ. Chem. 26, 99-109.
9. Pluess, N., Poiger, H., Hohbach, C., and Schlatter, C. (1988). Subchronic toxicity of some chlorinated dibenzofurans (PCDFs) and a mixture of PCDFs and chlorinated dibenzodioxins (PCDDs) in rats. Chemosphere 17, 973-984.
10. Pohjanvirta, R., and Tuomisto, J. (1994). Short-term toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in laboratory animals: Effects, mechanisms and animal models. Pharmacol. Rev. 46, 483-549.
11. Potter, C. L., Moore, R. W., Inhorn, S. L., Hagen, T. C., and Peterson, R. E. (1986). Thyroid status and thermogenesis in rats treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol. Appl. Pharmacol. 84, 45-55.
12. Potter, C. L., Sipes, G. L., and Haddock Russel, D. (1983). Hypothyroxinemia and hypothermia in rats in response to 2,3,7,8-tetrachlorodibenzo-p-dioxin administration. Toxicol. Appl. Pharmacol. 69, 89-95.
13. Rozman, K. K., Pfeifer, B., Kerecsen, L., and Alper, R. H. (1991). Is a serotonergic mechanism involved in 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced appetite suppression in the Sprague-Dawley rat? Arch. Toxicol. 65, 124-128.
14. Rozman, K. K., Stahl, B. U., Kerecsen, L., and Kettrup, A. (1995). Comparative toxicity of four chlorinated dibenzo-p-dioxins (CDDs) and their mixture. IV. Determination of liver concentrations. Arch. Toxicol. 69, 547-551.
15. Safe, S. (1990). Polychlorinated biphenyls (PCBs), dibenzo-p-dioxins (PCDDs), dibenzofurans (PCDFs), and related compounds: Environmental and mechanistic considerations which support the development of toxic equivalency factors (TEFs). Crit. Rev. Toxicol. 21, 51-88.
16. Safe, S. (1993). Development of bioassays and approaches for the risk assessment of 2,3,7,8-tetrachlorodibenzo-p-dioxin and related compounds. Environ. Health Perspect. 101 (Suppl. 3), 317-325.
17. Stahl, B. U., Beer, D. G., Weber, L. W. D., and Rozman, K. (1993). Reduction of hepatic phosphoenolpyruvate carboxykinase (PEPCK) activity by 2,3,7,8-tetrachlordibenzo-p-dioxin (TCDD) is due to decreased mRNA levels. Toxicology 79, 81-95.
18. Stahl, B. U., Kettrup, A., and Rozman, K. (1992). Comparative toxicity of four chlorinated dibenzo-p-dioxins (CDDs) and their mixture. Part I: Acute toxicity and toxic equivalency factors (TEFs). Arch. Toxicol. 66, 471-477.
19. Unkila, M., Pohjanvirta, R., MacDonald, E., and Tuomisto, J. (1993). Differential effect of TCDD on brain serotonin metabolism in a TCDD-susceptible and a TCDD-resistant rat strain. Chemosphere 27, 401-406.
20. Unkila, M., Pohjanvirta, R., MacDonald, E., Tuomisto, J. T., and Tuomisto, J. (1994). Dose response and time course of alterations in tryptophan metabolism by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the most TCDD-susceptible and the most TCDD-resistant rat strain: Relationship with TCDD lethality. Toxicol. Appl. Pharmacol. 128, 280-292.
21. Unkila, M., Pohjanvirta, R., and Tuomisto, J. (1995). Biochemical effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and related compounds on the central nervous system. Int. J. Biochem. Cell Biol. 27, 443-455.
22. Viluksela, M., Stahl, B. U., Birnbaum, L. S., and Rozman, K. K. (1997a). Subchronic/chronic toxicity of 1,2,3,4,6,7,8-heptachlorodibenzo-p-dioxin (HpCDD) in rats. Part II: Biochemical effects. Toxicol. Appl. Pharmacol. 146, 217-226.
23. Viluksela, M., Stahl, B. U., Birnbaum, L. S., Schramm, K.-W., Kettrup, A., and Rozman, K. K. (1997b). Subchronic/chronic toxicity of 1,2,3,4,6,7,8-heptachlorodibenzo-p-dioxin (HpCDD) in rats. Part I: Design, general observations, hematology and liver concentrations. Toxicol. Appl. Pharmacol. 146, 207-216.
24. Viluksela, M., Stahl, B. U., Birnbaum, L. S., Schramm, K.-W., Kettrup, A., and Rozman, K. K. (1998). Subchronic/chronic toxicity of a mixture of four chlorinated dibenzo-p-dioxins in rats. Part I: Design, general observations, hematology and liver concentrations. Toxicol. Appl. Pharmacol. 150, 57-69.
25. Viluksela, M., Stahl, B. U., and Rozman, K. K. (1995). Tissue-specific effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on the activity of phosphoenolpyruvate carboxykinase (PEPCK) in rats. Toxicol. Appl. Pharmacol. 135, 308-315.
26. Weber, L. W. D., Ernst, S. W., Stahl, B. U., and Rozman, K. (1993). Tissue distribution and toxicokinetics of 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats after intravenous injection. Fundam. Appl. Toxicol. 21, 523-534.
27. Weber, L. W. D., Lebofsky, M., Stahl, B. U., Kettrup, A., and Rozman, K. (1992a). Comparative toxicity of four chlorinated dibenzo-p-dioxins (CDDs) and their mixture. Part II: Structure-activity relationships with inhibition of hepatic phosphoenolpyruvate carboxykinase, pyruvate carboxylase, and γ-glutamyl transpeptidase activities. Arch. Toxicol. 66, 478-483.
28. Weber, L. W. D., Lebofsky, M., Stahl, B. U., Kettrup, A., and Rozman, K. (1992b). Comparative toxicity of four chlorinated dibenzo-p-dioxins (CDDs) and their mixture. Part III: Structure-activity relationships with increased plasma tryptophan levels, but no relationship to hepatic ethoxyresorufin O-deethylase activity. Arch. Toxicol. 66, 484-488.
29. Weber, L. W. D., Palmer, C. D., and Rozman, K. (1994). Reduced activity of tryptophan 2,3-dioxygenase in the liver of rats treated with chlorinated dibenzo-p-dioxins (CDDs): Dose-responses and structure-activity relationship. Toxicology 86, 63-69.